08-25 An undisclosed buyer acquired 7.19% stake in TASCOM Co.,Ltd. from Lee Seong-dong for approximately KRW 250 million. CI
01-22 TASCOM Co.,Ltd. announced that it has received KRW 1.999998 billion in funding CI
12-30 TASCOM Co.,Ltd. announced that it expects to receive KRW 1.999998 billion in funding CI
13/03/25 TASCOM Co., Ltd. announced that it has received KRW 300 million in funding CI
12/03/25 TASCOM Co., Ltd. announced that it expects to receive KRW 300 million in funding CI
12/12/24 TASCOM Co., Ltd. announced that it has received KRW 1.2999991 billion in funding CI
04/12/24 TASCOM Co., Ltd. announced that it expects to receive KRW 1.2999991 billion in funding CI
12/08/22 TASCOM Co.,Ltd. announced that it has received KRW 1.566576 billion in funding from SV Investment Corporation and other investors CI
29/06/22 TASCOM Co.,Ltd. announced that it expects to receive KRW 4.99995 billion in funding from SV Investment Corporation and other investors CI
24/12/21 YIDOBIO Inc. completed the acquisition of TASCOM CO.,LTD from Lee Seong-dong and other shareholders. CI
23/06/21 YIDOBIO Inc. entered into a merger agreement to acquire TASCOM CO.,LTD from Lee Seong-dong and other shareholders for KRW 89.6 billion. CI
16/02/21 YIDOBIO Inc. announced that it has received KRW 2.759978 billion in funding from Global Trading co.ltd, Korea Medix, Inc. CI
28/01/21 YIDOBIO Inc. announced that it expects to receive KRW 2.759978 billion in funding from Global Trading co.ltd, Korea Medix, Inc. and other investors CI
1 day-2.26%
1 week-4.88%
Current month-4.88%
1 month+44.44%
3 months+34.48%
6 months-7.14%
Current year+30.22%
1 week 3,700
Extreme 3700
4,200
1 month 2,700
Extreme 2700
4,200
Current year 1,800
Extreme 1800
4,715
1 year 1,800
Extreme 1800
5,280
3 years 1,800
Extreme 1800
11,000
5 years 1,800
Extreme 1800
29,250
10 years 1,800
Extreme 1800
31,000
Manager TitleAgeSince
Corporate Officer/Principal 54 24/05/2019
Chief Executive Officer 61 24/05/2019
Chief Operating Officer 55 -
Director TitleAgeSince
Director/Board Member 61 24/05/2019
Director/Board Member 54 24/05/2019
Director/Board Member 62 29/03/2019
Change 5-day change 1-year change 3-year change Capi.($)
-2.26%-4.88%+34.72%-60.96% 16.93M
-2.59%-3.13%-20.18%+4.76% 187B
-1.89%+0.38%-0.65%+15.55% 120B
-1.89%-1.90%+9.01%+82.72% 63.15B
-3.40%-5.18%+13.70%+44.83% 52.36B
-3.05%-4.29%-6.51%-32.86% 50.32B
-3.83%-6.22%+8.37%-18.99% 33.17B
-5.19%-1.20% - - 32.1B
-0.68%-0.29%+33.38%-14.12% 23.93B
-1.98%-7.53%-12.06%+6.09% 22.7B
Average -2.60%-1.14%+6.64%+3.00% 58.56B
Weighted average by Cap. -2.38%-0.77%-3.79%+14.18%

Financials

2017 2018
Net sales 2.99K 4.01M 2.57K 2.42K 2.21K 4.12K 284K 4.14K 28.67K 11.09K 145K 11.23K 10.99K 461K 5.53K 7.43M 4.76K 4.48K 4.09K 7.62K 525K 7.66K 53.04K 20.52K 268K 20.78K 20.33K 853K
Net income -1.29B -1,729B -1.11B -1.04B -951M -1.77B -122B -1.78B -12.35B -4.78B -62.43B -4.84B -4.73B -199B -1.74B -2,337B -1.5B -1.41B -1.29B -2.4B -165B -2.41B -16.69B -6.46B -84.4B -6.54B -6.4B -269B
Net Debt - -
Logo TASCOM Co.,Ltd.
Tascom Co Ltd, formerly YidoBio Inc is a Korea-based company principally engaged in the development of medical instruments. The Company develops and produces diabetes and pancreas care and treatment products including blood glucose meters, syringes, lancets, sharp containers and pen needles. In addition, the Company researches and develops diabetes treatment cell therapy products.
Employees
-
Date Price Change Volume
08/09/26 3,900.00 -2.26% 12
07/09/26 ₩3,990.00 -0.25% 16
04/09/26 ₩4,000.00 0.00% 12
03/09/26 ₩4,000.00 -2.44% 3
02/09/26 ₩4,100.00 -1.20% 17
  1. Stock Market
  2. Stocks
  3. A336040 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!